RACHEL WEST: Open Payments
NPI 1922613256 · MT PLEASANT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 59 payments from 27 companies in 2025. Trend: 2023 $784 · 2024 $1,236 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $116 |
| Incyte Corporation | 5 | $114 |
| PFIZER INC. | 4 | $104 |
| Myriad Genetic Laboratories, Inc. | 1 | $94 |
| Janssen Biotech, Inc. | 3 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Tempus AI, Inc | 4 | $88 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| Geron Corporation | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
Products named: JAKAFI, MYRISK, Nubeqa, XT CDX, KEYTRUDA, RYTELO, TECVAYLI, IMBRUVICA.
Industry payments across TX — which companies pay providers there.
